A study of teduglutide in Japanese children with short bowel syndrome who are 4 months or older.
The main aims of the study are to check for side effects from teduglutide.~Participants will receive a daily injection of teduglutide just under the skin (subcutaneous) for 24 weeks. Then they are followed up for another 4 weeks. Participants may be able to repeat this treatment if they meet specific criteria. The study doctors will check for side effects from teduglutide until it becomes commercially available. The maximum duration of treatment is approximately 18 months.